85
Growth Score in past quarter
pts
Heat Score 85 in past quarter
13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
207535
Link Biologics develops Link_TSG6, targeting inflammatory and degenerative disorders.
- Reuben Dawkins: Co-Founder and CEOPast Role: Novo Nordisk, Global Product Director
About the Company
Link Biologics is a biotechnology company focused on the development of Link_TSG6, a novel protein biological aimed at treating inflammatory and degenerative disorders. Originating as a spin-out from the University of Manchester, the company is engaged in preclinical research to advance Link_TSG6 towards clinical trials. With a small team of
dedicated professionals, Link Biologics is committed to transforming outcomes for individuals suffering from these conditions through their innovative biotechnological research and development efforts.